Buscador de publicacions

Publicacions

  • Muñoz JP, Cristina Larrosa Espinosa, Chamorro S, Pérez-Jaume S, Simao M, Sanchez-Sierra N, Varo A, Gorostegui-Obanos M, Castañeda-Heredia A, Garraus-Oneca M, Lopez-Miralles S and Mora J.

    Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes

    Cancers . 15(19): . Nº de cites: 2

    [doi:10.3390/cancers15194837]

  • Mora J, Castañeda-Heredia A, Gorostegui-Obanos M, Varo A, Pérez-Jaume S, Simao M, Muñoz JP, Garraus-Oneca M, Cristina Larrosa Espinosa, Salvador-Marcos N, Lavarino C, Krauel L and Mañe S.

    Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report

    Cancers . 15(9): . Nº de cites: 3

    [doi:10.3390/cancers15092535]

  • Torner-Rubies F, Nuñez JH, Inarejos E, Garraus-Oneca M, Suñol M, Deyà-Martinez A and Moreno-Romo D.

    Total calcaneal allograft reconstruction of an Ewing's sarcoma in a child: Outcome and review of the literature

    CANCER REPORTS . 5(9): . Nº de cites: 1

    [doi:10.1002/cnr2.1626]

  • Castañeda-Heredia A, Gorostegui-Obanos M, Miralles SL, ALICIA CHAMIZO BREMER, Patiño SC, Flores MA, Garraus-Oneca M, Lazaro JJ, Santa-María López V, Varo A, Muñoz JP and Mora J.

    How we approach the treatment of patients with high-risk neuroblastoma with naxitamab: experience from the Hospital Sant Joan de Deu in Barcelona, Spain

    ESMO Open . 7(2): 100462-100462. Nº de cites: 6

    [doi:10.1016/j.esmoop.2022.100462]

  • Inarejos E, Navarro OM, Navallas M, Enrique Ladera Gonzalez, Torner-Rubies F, Suñol M, Garraus-Oneca M, March JC and Barber-Martínez de la Torre I.

    Multiparametric MRI evaluation of bone sarcomas in children

    Insights into Imaging . 13(1): 33-33. Nº de cites: 4

    [doi:10.1186/s13244-022-01177-9]

  • Mora J, Castañeda-Heredia A, Gorostegui M, Santa-María V, Garraus-Oneca M, Muñoz JP, Varo A, Pérez-Jaume S and Mañe S.

    Naxitamab combined with granulocyte-macrophage colony-stimulating factor as consolidation for high-risk neuroblastoma patients in complete remission

    PEDIATRIC BLOOD & CANCER . 68(10): 29121. Nº de cites: 19

    [doi:10.1002/pbc.29121]

  • Castillo H, Pascual-Pastó G, Pérez-Jaume S, Resa-Parés C, Vilà-Ubach M, Monterrubio C, Jimenez-Cabaco A, Baulenas-Farrés M, Muñoz-Aznar O, Salvador-Marcos N, Cuadrado-Vilanova M, Gene-Olaciregui N, Balaguer-Lluna L, Burgeño-Sandoval V, Vicario FJ, Manzanares-Quintela A, Castañeda-Heredia A, Santa-María López V, Cruz-Martínez O, Celis-Passini V, Morales-La Madrid A, Garraus-Oneca M, Gorostegui M, Vancells M, Carrasco-Torrents R, Krauel L, Torner-Rubies F, Suñol M, Lavarino C, Mora J and Carcaboso AM.

    Prognostic value of patient-derived xenograft engraftment in pediatric sarcomas

    JOURNAL OF PATHOLOGY CLINICAL RESEARCH . 7(4): 338-349. Nº de cites: 11

    [doi:10.1002/cjp2.210]

  • Mora J, Castañeda-Heredia A, Colombo MC, Gorostegui M, Fernando Gómez Muñoz, Mañe S, Santa-María López V, Garraus-Oneca M, Macias N, Pérez-Jaume S, Muñoz-Aznar O, Muñoz JP, Barber-Martínez de la Torre I and Suñol M.

    Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma

    Cancers . 13(6): 164. Nº de cites: 7

    [doi:10.3390/cancers13061264]

  • Mora J, Castañeda-Heredia A, Flores MA, Santa-María V, Garraus-Oneca M, Gorostegui M, Simao M, Pérez-Jaume S and Mañe S.

    The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

    FRONTIERS IN PHARMACOLOGY . 11: 575009-575009. Nº de cites: 12

    [doi:10.3389/fphar.2020.575009]

  • Inarejos E, Navallas M, Barber Martínez de la Torre I, Suñol M, Munuera-del Cerro JL, Torner F, Garraus-Oneca M and Navarro OM.

    MRI of Rhabdomyosarcoma and Other Soft-Tissue Sarcomas in Children

    RADIOGRAPHICS . 40(3): 791-814. Nº de cites: 39

    [doi:10.1148/rg.2020190119]